François Briand, Estelle Grasset, Nicole Endlich, VedranDrenić, Blazej Dolicki, Thomas de Bel, Thierry Sulpice
Our aim was to validate and optimize a rat model of IgA nephropathy for drug efficacy studies using quantitative image analysis of kidney. To demonstrate the accuracy of our imaging methods, we evaluated atrasentan, a selective Endothelin A receptor Antagonist currently evaluated in phase III clinical trials.

26 October, 2024 • By Thomas de Bel

25 March, 2024 • By Jeroen van der Laak

01 October, 2022 • By Peter Bandi

13 January, 2022 • By Jeroen van der Laak

14 May, 2021 • By Jeroen van der Laak

01 October, 2020 • By Jeroen van der Laak

05 August, 2020 • By Jeroen van der Laak

01 February, 2020 • By Jeroen van der Laak